Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters

Table 3 Spearman’s rho correlation coefficient and P value between Miller-Payne grade and pretreatment tHb (maximum), oxyHb (maximum), deoxyHb (maximum), %tHb at day 7, and at the end of cycles 1, 2, 3, and 5, and before surgery

	tHb (max)	oxyHb (max)	deoxyHb (max)	%tHb day7	%tHb cycle 1	%tHb cycle 2	%tHb cycle 3	%tHb Cycle 5	%tHb before surgery
rho	0.43	0.28	0.46	0.26	0.61	0.57	0.43	0.26	0.29
P	P = 0.049	P = 0.205	P = 0.030	P = 0.321	P = 0.002	P = 0.006	P = 0.048	P = 0.321	P = 0.202

Data are from the new cohort (n = 22 patients)
deoxyHb deoxygenated hemoglobin, oxyHb oxygenated hemoglobin, tHb total hemoglobin

ISSN: 1465-542X